Jim Simons
PRPH

Jim Simons’s ProPhase Labs PRPH Stock Holding History

Jim Simons’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,010
Closed -$4.62K – 3655
2025
Q3 		$4.62K Sell
1,010
-12,782
-93% -$49.4K ﹤0.01% 3456
2025
Q2 		$54K Sell
13,792
-16,189
-54% -$54.1K ﹤0.01% 3384
2025
Q1 		$121K Buy
29,981
+1,332
+5% +$6.11K ﹤0.01% 3163
2024
Q4 		$217K Buy
28,649
+7,138
+33% +$100K ﹤0.01% 3143
2024
Q3 		$521K Sell
21,511
-540
-2% -$15.2K ﹤0.01% 2776
2024
Q2 		$922K Sell
22,051
-1,430
-6% -$74.9K ﹤0.01% 2369
2024
Q1 		$1.52M Sell
23,481
-1,090
-4% -$55.2K ﹤0.01% 2214
2023
Q4 		$1.11M Sell
24,571
-3,830
-13% -$175K ﹤0.01% 2339
2023
Q3 		$1.24M Sell
28,401
-1,650
-5% -$96.6K ﹤0.01% 2155
2023
Q2 		$2.18M Sell
30,051
-5,500
-15% -$448K ﹤0.01% 1940
2023
Q1 		$2.71M Sell
35,551
-3,390
-9% -$273K ﹤0.01% 1835
2022
Q4 		$3.75M Buy
38,941
+1,260
+3% +$136K 0.01% 1686
2022
Q3 		$4.25M Buy
37,681
+12,620
+50% +$1.47M 0.01% 1535
2022
Q2 		$3.18M Buy
25,061
+2,800
+13% +$246K ﹤0.01% 1871
2022
Q1 		$1.56M Sell
22,261
-500
-2% -$34.8K ﹤0.01% 2419
2021
Q4 		$1.63M Sell
22,761
-890
-4% -$55.4K ﹤0.01% 2299
2021
Q3 		$1.23M Sell
23,651
-5,081
-18% -$303K ﹤0.01% 2441
2021
Q2 		$1.78M Sell
28,732
-329
-1% -$18.5K ﹤0.01% 2333
2021
Q1 		$2.15M Buy
29,061
+1,560
+6% +$150K ﹤0.01% 2180
2020
Q4 		$2.52M Buy
27,501
+5,550
+25% +$465K ﹤0.01% 1978
2020
Q3 		$760K Buy
21,951
+1,881
+9% +$45.1K ﹤0.01% 2645
2020
Q2 		$289K Buy
20,070
+580
+3% +$9.61K ﹤0.01% 3055
2020
Q1 		$368K Buy
19,490
+230
+1% +$4.3K ﹤0.01% 2898
2019
Q4 		$379K Buy
19,260
+100
+0.5% +$1.96K ﹤0.01% 2990
2019
Q3 		$370K Buy
19,160
+370
+2% +$7.35K ﹤0.01% 2971
2019
Q2 		$404K Buy
18,790
+470
+3% +$13.8K ﹤0.01% 3074
2019
Q1 		$551K Buy
18,320
+620
+4% +$19.1K ﹤0.01% 2894
2018
Q4 		$558K Sell
17,700
-1,330
-7% -$40.4K ﹤0.01% 2818
2018
Q3 		$571K Buy
19,030
+160
+0.8% +$4.83K ﹤0.01% 2811
2018
Q2 		$613K Buy
18,870
+3,150
+20% +$104K ﹤0.01% 2770
2018
Q1 		$465K Sell
15,720
-822
-5% -$20.9K ﹤0.01% 2938
2017
Q4 		$359K Buy
16,542
+976
+6% +$21.3K ﹤0.01% 2966
2017
Q3 		$333K Buy
15,566
+2,210
+17% +$47.5K ﹤0.01% 2882
2017
Q2 		$279K Buy
13,356
+1,816
+16% +$36.4K ﹤0.01% 2922
2017
Q1 		$262K Buy
11,540
+500
+5% +$10.1K ﹤0.01% 2945
2016
Q4 		$221K Buy
11,040
+370
+3% +$7.47K ﹤0.01% 2975
2016
Q3 		$210K Buy
10,670
+640
+6% +$11K ﹤0.01% 3059
2016
Q2 		$131K Buy
10,030
+190
+2% +$2.56K ﹤0.01% 3124
2016
Q1 		$138K Buy
9,840
+320
+3% +$4.01K ﹤0.01% 3163
2015
Q4 		$143K Buy
9,520
+820
+9% +$11.9K ﹤0.01% 3064
2015
Q3 		$137K Buy
8,700
+2,580
+42% +$38.7K ﹤0.01% 2963
2015
Q2 		$83K Buy
6,120
+1,060
+21% +$14.2K ﹤0.01% 3108
2015
Q1 		$66K Buy
5,060
+290
+6% +$4.27K ﹤0.01% 3054
2014
Q4 		$70K Buy
4,770
+400
+9% +$5.53K ﹤0.01% 2845
2014
Q3 		$61K Buy
4,370
+810
+23% +$12.6K ﹤0.01% 2702
2014
Q2 		$60K Sell
3,560
-1,158
-25% -$21.4K ﹤0.01% 2705
2014
Q1 		$94K Sell
4,718
-1,532
-25% -$29.1K ﹤0.01% 2714
2013
Q4 		$101K Sell
6,250
-430
-6% -$7.74K ﹤0.01% 2724
2013
Q3 		$127K Hold
6,680
– – ﹤0.01% 2658
2013
Q2 		$104K Buy
+6,680
New +$104K ﹤0.01% 2618

Other funds holding PRPH

SC
Sykon Capital Harrison, New York $300M AUM 16.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Jim Simons's PRPH Position: Q4 2025 in Review

Jim Simons sold out of ProPhase Labs (PRPH) in Q4 2025, closing a stake of 1,010 shares — an estimated $4.62K sold.

Jim Simons first reported a position in PRPH in Q2 2013 and held it in 50 quarters. The position peaked at $4.25M in Q3 2022. 17 funds tracked by Wall St. Rank hold PRPH as of Q4 2025.

  • Jim Simons reported no remaining ProPhase Labs position as of Q4 2025 after selling out during the quarter.
  • Jim Simons sold 1,010 ProPhase Labs shares in Q4 2025, an estimated $4.62K.
  • Jim Simons first reported a position in ProPhase Labs in Q2 2013 and held it in 50 quarters.
  • Jim Simons's ProPhase Labs position peaked at $4.25M in Q3 2022.
  • 17 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.